By
Trending Posts
Could the Algen Biotechnologies – AstraZeneca $555 Million…
Key Highlights / Executive Take-aways: Strategic Significance of the PartnershipThe alliance between Algen Biotechnologies and AstraZeneca marks a…
Can Takeda and Nabla Bio’s $1 Billion AI…
Key Highlights: AI Takes Center Stage in Takeda’s R&D RebootAfter narrowing its research focus to small molecules, biologics,…
Could Cohere’s New Paris Office Accelerate AI Adoption…
Key Insights: Expanding Footprint in Europe Cohere, a Canadian AI firm known for developing large language models and…
Could Aiforia and Siemens Healthineers Transform Digital Pathology…
Key Insights: Strategic Partnership to Expand AI Pathology Aiforia Technologies Plc announced a major collaboration with Siemens Healthineers…
Can Ant Group’s AQ AI Health App Redefine…
Key Highlights Expanding AI Access in HealthcareSince its launch in June 2025, Ant Group’s AQ AI Health App…
Can GHX’s AI-Driven Supply Chain Solutions Transform How…
Key Highlights AI reshaping healthcare supply chains: Unlike retail or tech, healthcare requires flawless delivery—any delay can directly…
Is Stanford’s MedAgentBench Setting the New Gold Standard…
Key Highlights AI benchmarking moves beyond knowledge tests: Unlike earlier evaluations that focused on exams like the USMLE,…
Will Apple’s FDA-Cleared Hypertension Detection Feature on the…
Key Highlights FDA Approval Unlocks a New Era in Preventive CareApple’s hypertension detection feature, cleared by the U.S.…
Is Novartis Deepening Its Bet on AI-Enabled Molecular…
Novartis AG (SIX: NOVN; NYSE: NVS), a global leader in immunology and targeted therapies, has broadened its partnership…
Trending Posts
Latest Stories
Could the Algen Biotechnologies – AstraZeneca $555 Million AI-Driven Drug-Discovery Pact Redefine How Immunology Therapies Are Developed?
Key Highlights / Executive Take-aways: Strategic Significance of the PartnershipThe alliance between Algen Biotechnologies and…
Can Takeda and Nabla Bio’s $1 Billion AI Alliance Redefine the Future of Protein Therapeutics?
Key Highlights: AI Takes Center Stage in Takeda’s R&D RebootAfter narrowing its research focus to…
Could Cohere’s New Paris Office Accelerate AI Adoption Across Europe’s Healthcare and Biopharma Sector?
Key Insights: Expanding Footprint in Europe Cohere, a Canadian AI firm known for developing large…
Could Aiforia and Siemens Healthineers Transform Digital Pathology Across Europe With AI?
Key Insights: Strategic Partnership to Expand AI Pathology Aiforia Technologies Plc announced a major collaboration…
Gallery
